Click Here for Additional Information About Our Possible Medical Indications!

Zhittya Genesis Medicine is working to treat diseases which are responsible for the deaths of millions throughout the world. A lack of blood flow is responsible for varied and heterogeneous diseases ranging from coronary artery disease to stroke, and diabetic foot ulcers to vascular dementia. Lack of blood flow is also speculated to be the cause of other neurodegenerative diseases such as Parkinson's and Alzheimer's. Zhittya Genesis Medicine's administration has expended over 20 years of effort and over $150,000,000 USD in developing a biological drug, FGF-1, which is capable of growing new blood vessels in ischemic tissue in a process known as angiogenesis. By growing new blood vessels in the human body, Zhittya believes that FGF-1 could reverse the root causes of those aforementioned vascular diseases by reestablishing the blood flow in the parts of the body that need it most.

FGF-1

Our drug, FGF-1, is a naturally occurring biological protein responsible for the growth of new blood vessels in the human body (angiogenesis) and can promote the growth of new neurons (neurogenesis).

Natural Angiogenesis

Angiogenesis, the growth of new blood vessels, occurs every time you get a cut, scrape, or other injury. Growth factors, such as FGF-1, promote blood vessel growth. Our theory is that slow and debilitating diseases do not have an initiating event, such as a scrape or cut, that results in natural angiogenesis. By introducing FGF-1, we believe we can resolve the issue of the slow and debilitating ischemia.